With the harmonisation of data requirements for pesticide registration under EC Directive 91/414 there is need for progress on the techniques used to analyse such data and so help make consistent the judgements applied by national regulatory authorities. This paper proposes a Bayesian technique for
Bayesian approaches to the value of information: implications for the regulation of new pharmaceuticals
β Scribed by Karl Claxton
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 51 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1057-9230
No coin nor oath required. For personal study only.
β¦ Synopsis
The current regulation of new pharmaceuticals is inefficient because it demands arbitrary amounts of information, the type of information demanded is not relevant to decision-makers and the same standards of evidence are applied across different technologies. Bayesian decision theory and an analysis of the value of both perfect and sample information is used to consider the efficient regulation of new pharmaceuticals. This type of analysis can be used to decide whether the evidence in an economic study provides 'sufficient substantiation' for an economic claim, and assesses whether evidence can be regarded as 'competent and reliable'.
π SIMILAR VOLUMES
A procedure that permits rapid development of an optimized solid phase extraction (SPE) method for the analysis of drugs in plasma by on-line solid phase extraction-mass spectrometry (SPE-MS) has been developed. This procedure employs the concept of manipulating the pH and the percentage of organic